Product
MBS-COV
2 clinical trials
1 indication
Indication
COVID-19Clinical trial
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of SNS812 in Participants With Mild to Moderate COVID-19Status: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy ParticipantsStatus: Completed, Estimated PCD: 2023-03-30